| Literature DB >> 31318414 |
He-Yong Tang1, Ai-Juan Jiang1, Jun-Long Ma1, Fan-Jing Wang1, Guo-Ming Shen1.
Abstract
Worldwide, the most prevalent metabolic disorder is diabetes mellitus (DM), an important condition that has been widely studied. Diabetic peripheral neuropathy (DPN), a complication that can occur with DM, is associated with pain and can result in foot ulcers and even amputation. DPN treatments are limited and mainly focus on pain management. There is a clear need to develop treatments for DPN at all stages. To make this progress, it is necessary to understand the molecular signaling pathways related to DPN. For this review, we aimed to concentrate on the main signaling cascades that contribute to DPN. In addition, we provide information with regard to treatments that are being explored.Entities:
Year: 2019 PMID: 31318414 DOI: 10.1210/en.2019-00311
Source DB: PubMed Journal: Endocrinology ISSN: 0013-7227 Impact factor: 4.736